Navigation Links
The race toward an interferon free world: The current field of Hepatitis C Virus treatment research, including recent financial deals
Date:4/26/2013

NEW YORK, April 26, 2013 /PRNewswire/ -- Citeline®, an Informa business unit, and the world's leading research authority on pharmaceutical clinical trials has just published an exclusive whitepaper examining the current progress towards a remarkable improvement in the medical treatment for HCV.

(Logo: http://photos.prnewswire.com/prnh/20120917/NE75453LOGO

With news of the impending breakthrough in HCV treatment, Citeline reviews the current landscape of clinical trials and drugs in this competitive space as well as the recent history of HCV-related financial deals.  In addition the whitepaper takes a look at the timing of current Phase III trials evaluating all oral regimens to determine how long Gilead may be the sole player in this space.  

Based on information in Citeline's clinical trial intelligence tool, Trialtrove®, 83% of the 200 planned and ongoing Phase I-III clinical trials for pipeline HCV drugs (excluding vaccines) are being conducted by 10 companies; these 10 companies, including Bristol-Myers Squibb, Gilead, Merck and AbbVie, among others, are the focus of this report. Gilead leads in the number of Phase II trials and is conducting over twice as many as the next most active Phase II sponsor, Bristol-Myers Squibb.

According to Doro Shin , MPH, Citeline's Senior Analyst, Infectious & Genitourinary Diseases, "Gilead's lead in direct acting antiviral (DAA) agents for the treatment of HCV could lead to a shorter, oral, and interferon free treatment of the disease, with a dramatic reduction in unwanted side effects. This is truly a new era in HCV treatment. "

Moreover, in reviewing deals over the last five years we discovered between March 2008 and March 2013, there were a total of 18 HCV specific industry partnerships. In both years partnerships comprised of r
'/>"/>

SOURCE Citeline
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
2. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
3. Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
4. Medical Marijuana Inc. and Canipa Holdings Drive Dixie X and CanChew Gum Toward EU Marketing Approval And Clinical Development
5. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
6. Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region
7. The Shift from Treatment to Prevention: A Drive towards Cutting Healthcare Costs
8. Emerging Growth Pharmaceutical Company Creates Gravitational Pull Towards Their Products
9. In Vitro Diagnostics Markets Grow at Double the Pace of Pharma Markets in Shift toward Globalization
10. Optimism of Cannabis Patients Creates More Demand for Phytiva Brand of Cannabinoid Solutions as Illinois and New Hampshire Take Key Legislative Steps Toward Legalization of Medical Cannabis
11. Novartis signs on to support Malaria No Mores Power of One campaign to stride towards a future without malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- Foundation Health Care  (FDNH), which owns and operates hospitals ... it will present at the LD Micro Invitational Conference ... Boulevard Hotel, Los Angeles, CA. ... at 3:00pm and will also be available for ... LD Micro. For more information about the conference, please ...
(Date:5/27/2015)... , May 27, 2015  Genomic Health, Inc. (Nasdaq: ... Operating Officer and Chief Financial Officer, will present at the ... City on Monday, June 1 at 8:30 a.m. ... subsequently archived webcast of the presentation, go to the  Investor ... .  Please connect to the web site at least 15 ...
(Date:5/27/2015)... , May 25, 2015 Research and Markets ... the "Research and Future Development Trend Forecast of ... At present, there are 35,600 dialysis centers ... ratio are large due to the different regional operating ... centers in other Asian countries are operated by state-owned ...
Breaking Medicine Technology:Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3China Dialysis Market Report: Research and Future Development Trends and Forecasts 2015-2020 2
... 19, 2011 ICAP Patent Brokerage , ... intellectual property brokerage and patent auction firm, is ... major medical device company. The available portfolios disclose ... control, high-intensity focused ultrasound (HIFU) energy, improved blood ...
... SAN DIEGO, Oct. 19, 2011 CareFusion (NYSE: ... following update regarding its recall of 128 EnVe™ ventilators affecting ... Class I recall. The voluntary recall only ... and therefore, has no affect on the company,s current product ...
Cached Medicine Technology:Global Leader in Medical Technology Offers for Sale Seven Patent Portfolios Through ICAP Patent Brokerage 2Global Leader in Medical Technology Offers for Sale Seven Patent Portfolios Through ICAP Patent Brokerage 3CareFusion Initiates Class I Recall of EnVe Ventilators 2
(Date:5/27/2015)... May 27, 2015 SAN DIEGO, ... Gulfport Mississippi, is the first healthcare provider along ... to chronic care management (CCM). In partnership with ... is introducing RevUp, a new program that enables ... and increase monthly reimbursements. This new, user-friendly program ...
(Date:5/27/2015)... May 27, 2015 Coco Libre announced today ... able to reach for Organic Coconut Water to quench their ... be available at VIP areas, artist greenrooms, corporate skyboxes and ... at area hotels and on festival shuttle buses. , ... year,” said Noa Elan, Director of Strategic Partnerships for Latitude ...
(Date:5/27/2015)... 27, 2015 This is a ... of the Omega-3 industry. The report provides a ... applications and industry chain structure. The Omega-3 market ... development trends, competitive landscape analysis, and key regions ... Camanchaca Fishing Company, Seadragon Marine Oils, Norwegian Fish ...
(Date:5/27/2015)... With InnerVoice Communication App you will ... is not only heard but seen -- by a photograph ... image. This award-winning and affordable app takes full advantage of ... InnerVoice Sender app in conjunction with InnerVoice Communication ... remotely for no additional cost. , InnerVoice Sender ...
(Date:5/27/2015)... For a limited time, San Fernando ... discounts on facial fillers. Skin loses more than 2 percent ... This lost collagen can lead to thinning or sagging skin, ... Facial fillers are an excellent way to plump skin and ... to create a softer and more youthful appearance, without the ...
Breaking Medicine News(10 mins):Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2
... Announced the Initiation of the Phase III ... to Treat Rheumatoid Arthritis., COPENHAGEN, Denmark, November 20 ... GSK) announced today the,initiation of the Phase III program ... commence with two studies,(GEN410/OFA110635 and GEN411/OFA110634) which will be ...
... November 20 With the recent,FDA approval of ... and follow-up of cancerous or other potentially malignant,lesions ... Technologies,succeeds in setting the trend in diagnostic oncology ... Lesion Management Solutions at the,93rd annual meeting of ...
... Nov. 16 For patients with,rheumatoid arthritis, combining one ... medications often works best to reduce joint,swelling or tenderness, ... for,Healthcare Research and Quality, part of the U.S. Department ... report will be posted on-line,Monday in the Annals of ...
... 19 If you or someone you know,has been ... or medical,personnel working with lung cancer patients, you won,t ... Advocacy Conference. The conference,co-presented by the American Lung Association ... be held Friday, Nov. 30, at the,Ritz-Carlton Dearborn. Medical ...
... healthy individuals, have made a key discovery in understanding ... and remain untreated by the bodys own natural defences. ... 23 November) by the Proceedings of the National Academy ... , Under normal circumstances, the immune system creates ...
... studies suggest , , MONDAY, Nov. 19 (HealthDay News) -- People ... and dementia as they age, two new studies suggest. ... pressure increased the risk of developing disabilities, such as not ... or bathe oneself. , "High blood pressure affects many ...
Cached Medicine News:Health News:Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program 2Health News:Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program 3Health News:Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program 4Health News:MEDIAN Technologies Lesion Management Solutions Set the Trend in Diagnostic Oncology Imaging at RSNA 2007 2Health News:Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis 2Health News:Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis 3Health News:BREATHE Lung Cancer Conference, Nov. 30, Offers Medical and Patient Education, Advocacy and Survivor's Perspective 2Health News:BREATHE Lung Cancer Conference, Nov. 30, Offers Medical and Patient Education, Advocacy and Survivor's Perspective 3Health News:BREATHE Lung Cancer Conference, Nov. 30, Offers Medical and Patient Education, Advocacy and Survivor's Perspective 4Health News:BREATHE Lung Cancer Conference, Nov. 30, Offers Medical and Patient Education, Advocacy and Survivor's Perspective 5Health News:BREATHE Lung Cancer Conference, Nov. 30, Offers Medical and Patient Education, Advocacy and Survivor's Perspective 6Health News:New research helps explain how tumors go undetected by the body 2Health News:High Blood Pressure Linked to Disability, Dementia 2Health News:High Blood Pressure Linked to Disability, Dementia 3
... portable NEVA™ System is designed ... changes within the penis nocturnally. ... to monitor and record impedance ... changes in penile blood volume. ...
... designed for vascular labs already equipped ... Its primary use will be for ... cuff with air. Blood pressures ... - a proximal occluding cuff connected ...
... your patients come to you with ... they can understand. Then they want ... Rigidity Assessment System can you gather, ... rigidity and tumescence data...and provide the ...
... The table top design takes into ... and creates a flexible working environment for ... the alphamaxx can be matched exactly to ... top slide capability creates superior access for ...
Medicine Products: